The shift that changes what marketing must do
Danone's FY 2025 results, published in its full-year press release, show total sales of €27,283 million, up 4.5% on a like-for-like basis. Volume and mix contributed +2.7 percentage points. Pricing contributed +1.8 percentage points. That is the first time since 2022 that the volume side of the equation has outpaced the price side.
For a commercial leader, that single data point reframes the role of the marketing budget. When a business runs on 6 to 8% annual price rises, as Danone did during the inflation cycle, brand investment is largely defensive. Consumers are paying more regardless, and the job of advertising is mainly to prevent switching. When pricing slows to under 2% and volume has to carry the growth, brand investment becomes offensive. You need people to pick your product off the shelf, not just accept its new price.
That is the environment Danone's brand teams are now operating in, and it makes every marketing decision from here more consequential.
What the numbers say about growth composition
The FY 2025 press release shows Q4 closing at +4.7% like-for-like, a slight acceleration on the full-year figure. The mix component, meaning the shift toward higher-value products within Danone's portfolio, is doing real work. That points toward premiumisation as an active strategy, not a passive one.
Danone's three main business areas are Essential Dairy and Plant-Based, Specialised Nutrition, and Waters. The mix engine growing faster than the rate engine suggests that Specialised Nutrition, which includes infant formula and medical nutrition and tends to carry higher margins and stronger brand loyalty, is a likely contributor to positive mix. This is directional reading from the overall split, not a segment-level disclosure, but it is consistent with Danone's stated priority of growing its highest-margin categories.
The infant formula shadow
Any marketing strategy Danone builds around its Specialised Nutrition portfolio now has to account for a significant reputational event. A cereulide contamination incident in late 2025 triggered a major product recall across nearly 100 countries, affecting Danone alongside Nestlé and Lactalis, according to reporting by Dairy Reporter.
Recalls at this scale do not disappear from the category conversation quickly. For Danone's infant nutrition brands, the marketing task is now partly about trust restoration, not just awareness or trial. That typically shifts spend toward healthcare professional channels, point-of-care communication, and earned media around safety and quality credentials rather than consumer-facing advertising. It is not a cheap pivot, and it competes for budget with brand-building work in the dairy and plant-based business.
Regenerative agriculture as a brand message, and its limits
Danone has invested in regenerative agriculture sourcing, and the temptation to build marketing around that platform is real. But the trade signals here are cautionary. Reporting from FoodNavigator cites Dr Robert Gerlach, CEO of agtech firm Klim, saying directly: "Consumers don't care about food sustainability." Inflationary pressure has pushed planetary concerns down shoppers' priority lists, and few consumers understand what regenerative agriculture means, let alone pay a premium for it.
The implication for Danone is that sustainability messaging needs to be routed through personal health and nutrition benefits, not environmental ones, if it is going to move product. "Better for you because it comes from healthier soil" lands better than "better for the planet." That is a marketing framing challenge, and it affects which media channels and creative briefs make sense.
The ageing consumer opportunity in specialised nutrition
One area where Danone's marketing investment has a clear tailwind is older adult nutrition. FoodNavigator analysis projects the global elderly nutrition market reaching $43.1 billion by 2032, driven by structural demographic shifts. Key nutrients for this cohort include protein, B12, calcium, and omega-3 fatty acids, all of which sit naturally within Danone's existing product formulations across dairy and medical nutrition.
Marketing to older consumers requires different channels and a different tone than yogurt advertising aimed at young families. Healthcare professional endorsement carries more weight. Pharmacy and clinical retail channels matter more. If Danone is moving marketing spend toward this cohort, as the mix data suggests is commercially logical, you would expect to see more investment in healthcare provider programmes and less in mass-market consumer media.
What to watch next
The clearest signal to track is how Danone's marketing-to-sales ratio moves in first-half 2026 reporting. If volume and mix are expected to keep outpacing pricing, the company has an incentive to invest more in brand pull, not less. Watch for any disclosure around advertising and promotional spend as a percentage of sales in the next set of results.
The infant formula recall and its resolution timeline will also shape where Specialised Nutrition marketing budgets go. Trust repair in infant nutrition is slow, and any incremental disclosure about recall scope or market re-entry timing would materially affect how you read Danone's near-term brand investment priorities in that segment.
Finally, the mix shift toward higher-value products is a positive signal, but it only holds if consumers keep choosing up rather than trading down. If consumer confidence softens in Danone's key European markets, the volume growth story gets harder, and so does the case for sustained brand investment at current or higher levels.